- 萊美藥業
- 5.560-0.260 (-4.467%)
盈利能力分析
- -1.277
- -0.425
- -3.210
- -6.042
- -23.960
- -0.891
- -0.300
- -2.297
- -3.310
- -9.829
- -1.071
- -0.360
- -2.799
- -4.112
- -12.272
邊際利潤分析
- 63.401
- 69.330
- 73.498
- 71.466
- 68.089
- -6.738
- 6.278
- -10.857
- -5.725
- -21.856
- -4.076
- -2.123
- -7.963
- -7.057
- -16.340
- -2.563
- -1.119
- -8.624
- -8.646
- -21.765
收益指標分析
- 506.545
- -2,145.438
- 151.840
- 119.260
- 51.999
- 165.658
- 2,421.015
- -7.682
- -45.226
- -0.983
- -281.434
- -1,464.312
- -27.631
- 33.806
- -0.724
償債能力分析
- 2.355
- 2.928
- 2.489
- 2.590
- 0.997
- 2.108
- 2.624
- 2.201
- 2.353
- 0.823
- 30.600
- 26.591
- 28.483
- 24.418
- 60.874
- 16.333
- 11.579
- 14.840
- 7.790
- 46.932
- 505.206
- 735.392
- 568.487
- 1,157.975
- 99.850
- 221.208
- 270.667
- 244.128
- 301.736
- 61.128
- 1.765
- 0.841
- -14.654
- -4.432
- -3.049
營運能力分析
- 136.557
- 131.612
- 153.285
- 133.152
- 127.609
- 221.487
- 244.692
- 276.541
- 233.973
- 218.488
傾力救市
貨幣攻略
More